A detailed history of National Bank Of Canada transactions in Novartis Ag stock. As of the latest transaction made, National Bank Of Canada holds 116,898 shares of NVS stock, worth $11.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
116,898
Previous 116,898 -0.0%
Holding current value
$11.7 Million
Previous $13.4 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $6.48 Million - $7.39 Million
-61,102 Reduced 34.33%
116,898 $13.4 Million
Q2 2024

Aug 02, 2024

BUY
$92.57 - $107.37 $2.94 Million - $3.42 Million
31,812 Added 21.76%
178,000 $18.9 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $486,258 - $553,630
5,104 Added 3.62%
146,188 $14.1 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $112,569 - $123,878
1,220 Added 0.87%
141,084 $14.2 Million
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $436,231 - $484,123
4,605 Added 3.4%
139,864 $14.2 Million
Q2 2023

Jul 26, 2023

BUY
$92.52 - $104.91 $167,831 - $190,306
1,814 Added 1.36%
135,259 $13.6 Million
Q1 2023

Apr 12, 2023

SELL
$80.03 - $92.81 $942,433 - $1.09 Million
-11,776 Reduced 8.11%
133,445 $12.3 Million
Q4 2022

Jan 24, 2023

BUY
$75.55 - $92.52 $77,212 - $94,555
1,022 Added 0.71%
145,221 $0
Q3 2022

Oct 13, 2022

BUY
$74.61 - $87.26 $521,523 - $609,947
6,990 Added 5.09%
144,199 $10.9 Million
Q2 2022

Jul 28, 2022

BUY
$80.52 - $93.75 $928,073 - $1.08 Million
11,526 Added 9.17%
137,209 $11.6 Million
Q1 2022

May 05, 2022

SELL
$80.11 - $90.62 $1.76 Million - $1.99 Million
-21,912 Reduced 14.85%
125,683 $10.9 Million
Q4 2021

Jan 24, 2022

BUY
$79.7 - $88.13 $11.8 Million - $13 Million
147,595 New
147,595 $12.9 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.